Researchers testing non-drug treatment for fibromyalgia

October 9, 2014 by Keith Herrell
Lesley Arnold, MD, is leading a clinical trial testing a non-drug treatment for fibromyalgia.

Researchers at the University of Cincinnati (UC) are testing a non-drug treatment for fibromyalgia, a condition characterized by chronic and widespread pain.

UC is one of 16 centers participating in the trial, testing a therapy known as "Reduced Impedance Noninvasive Cortical Electrostimulation" (RINCE) in the treatment of associated with fibromyalgia. Lesley Arnold, MD, a professor in the UC Department of Psychiatry and Behavioral Neuroscience and UC Health physician, is the principal investigator at UC, the only center in Ohio, Indiana and Kentucky participating in the trial.

"This is a phase-3 clinical trial, designed to test the safety and efficacy of a device for possible approval by the Food and Drug Administration," says Arnold, adding that it's one of the first trials of a non-drug treatment for fibromyalgia.

In addition to pain, fibromyalgia is characterized by other symptoms including fatigue, sleep disturbance and cognitive symptoms such as forgetfulness or decreased concentration. It has a prevalence of about 2 percent of the U.S. population, according to the U.S. Centers for Disease Control and Prevention, and is about seven times more common in women than in men.

The device under study is called NeuroPoint and is manufactured by Cerephex Corporation, a privately held medical technology company that is sponsoring the trial. (Arnold reports no conflicts.) NeuroPoint delivers gentle electrical stimulation to specific areas in the brain that may be involved in overactive pain perception for fibromyalgia sufferers. The goal is to reduce the overactivity in a way that might help reduce the perception of pain. (While no one knows the exact cause of , evidence shows that it may be related to overactive brain activity, which causes pain to be processed and felt at higher levels than normal.)

Men and women ages 22 to 65 are eligible for the study, which expects to enroll about 200 volunteers nationally. Volunteers undergo treatment at the Stetson Building, home of the UC Department of Psychiatry and Behavioral Neuroscience and UC Health Psychiatry, near UC Medical Center. Patients are seated during treatment, which is non-invasive (an electrode is used on the scalp, but no skin is pierced).

Treatment sessions, lasting about 20 minutes, are spread out over a 12-week period with two sessions per week. Patients receive study-related care at no cost and will be compensated for time and travel.

Volunteers will be randomized into two groups, with half receiving NeuroPoint treatment and half receiving a sham in which the device is activated but no therapy is delivered. It's a , meaning neither the volunteer nor the caregiver will know which group the patient is part of.

Explore further: Cold weather hits fibromyalgia sufferers hard

Related Stories

Cold weather hits fibromyalgia sufferers hard

January 31, 2014
Cold temperatures, such as those gripping the Midwest over the past week, are tough on everybody. But for individuals with fibromyalgia, whose symptoms include chronic, widespread pain, the big freeze is especially difficult ...

Fibromyalgia and the role of brain connectivity in pain inhibition

October 1, 2014
The cause of fibromyalgia, a chronic pain syndrome is not known. However, the results of a new study that compares brain activity in individuals with and without fibromyalgia indicate that decreased connectivity between pain-related ...

Hypersensitivity to non-painful events may be part of pathology in fibromyalgia

September 15, 2014
New research shows that patients with fibromyalgia have hypersensitivity to non-painful events based on images of the patients' brains, which show reduced activation in primary sensory regions and increased activation in ...

Chronic Fatigue Syndrome challenges patients, medical professionals

July 1, 2011
(Medical Xpress) -- We all get a little tuckered out now and then, but when that tired feeling doesn’t go away with what’s considered normal rest and relaxation there are a myriad of medical conditions that can ...

Lyrica may ease pain for depressed fibromyalgia patients

October 28, 2013
(HealthDay)—Fibromyalgia and depression often go hand in hand, and a new study finds that the drug Lyrica helps ease pain in patients being treated for both conditions.

Psychological intervention reduces disability and depression in adolescents with fibromyalgia

November 22, 2011
A recent trial shows cognitive-behavioral therapy (CBT) reduces functional disability and depressive symptoms in adolescents with juvenile fibromyalgia. The psychological intervention was found to be safe and effective, and ...

Recommended for you

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

Migraines may be the brain's way of dealing with oxidative stress

October 19, 2017
A new perspective article highlights a compelling theory about migraine attacks: that they are an integrated mechanism by which the brain protects and repairs itself. Recent insightful findings and potential ways to use them ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

julianpenrod
1 / 5 (2) Oct 09, 2014
Painkillers and anti -depressants. Physical therapy. Spinal fusion. Now electro cortical stimulation. An old tenet is that, if a vast variety of methods are tried to solve a problem and none of them works, then those purportedly trying to solve the problem are not looking in the right place.
And that's the case here, none are looking in the right spot! In fact, they are all deliberately, calculatedly looking absolutely everywhere except one spot!
"Fibromyalgia" is caused by herniated disks, especially in the cervical spine. All the nerves go up the spinal column and just about every nerve goes through the cervical disks. A slippage can cause pressure on nerves that can create pressure on nerves giving rise to phantom pains! Which is why there is nothing seen anywhere in the body that causes the symptoms of "fibromyalgia"! Because there's nothing there! Chiropractic with an emphasis on decompression will solve "fibromyalgia".

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.